CLARIANE falls this Tuesday mid-session. The stock is down to 4.07 euros, losing 9.48% compared to Monday's close. Although the third-quarter results show good operational momentum, it is primarily the downward revision of profitability targets that triggers the market's reaction.
At 4.0680 euros, CLARIANE drops 9.48% compared to Monday's close (4.49 euros). The stock has declined by 6.18% over seven days and 18.02% over three months, indicating a gradual retreat over several weeks. On an annual perspective, it still records a growth of 112.9%, significantly outperforming the CAC 40, which has risen by 9.81% over the same period. The Paris index itself remains almost stable this Tuesday with a slight decrease of -0.07%. Trading remains moderate with a traded share capital of 0.5%, a typical indication of a quick market reaction to a strategic announcement without major overflow in transaction volumes.
Financial Performance and Market Reaction
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The group posted a revenue for the third quarter of 3.976 billion euros, up by 1.1% on a reported basis and 4.9% in organic growth. Germany, the group's second-largest market, grew by 5.7%, while France saw a decline of 1.7%. CLARIANE confirmed its annual revenue growth targets for 2025 at 5% in organic terms. The real disappointment lies in profitability. This correction reflects less robust profitability ambitions than the market had expected. Oddo BHF immediately lowered its price target, confirming that analysts are revising the risk-return profile of the stock downwards.
Technical Analysis
Technically, CLARIANE is trading between the 50-day moving average at 4.38 euros above the current price and the 200-day moving average at 4.06 euros below, providing short-term support. The RSI remains at 53, reflecting a neutral position. Negative on-balance volume and a very low cash flow multiplier at 0.03 indicate an accumulation of selling pressures. The monthly volatility is recorded at 12.04.
SectorSanté · Etablissements de santé / EHPAD›Etablissements de santé
Context
Period
Period: 1T2026
Key reported figures
Revenue: 1336M€
Guidance from the release
Avec une croissance organique de 4,9 %, le premier trimestre 2026 s’inscrit pleinement dans la dynamique.
Le chiffre d’affaires au 31 mars 2026 s’établit à €1 336m, en progression de +4,9%.
Risks mentioned
Impact des cessions intervenues en 2025 dans le cadre du plan de renforcement.
Risque lié aux conditions de marché futures.
Effets des défis réglementaires dans le secteur.
Opportunities identified
Lancement d'une obligation senior de €500m à échéance 2031.
Nouvelle dynamiqueprix/volume grâce aux mesures d’adaptation mises en place.
Engagement fort des collaborateurs pour atteindre les objectifs opérationnels.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.